Rezolute (RZLT) Non Operating Income (2012 - 2026)
Rezolute (RZLT) reported Non Operating Income of $1.2 million for Q1 2026, up 7.75% on a YoY basis from $1.1 million in Q1 2025, and down 17.42% sequentially from $1.4 million in Q4 2025.
Rezolute (RZLT) Non Operating Income (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 15 years of Non Operating Income data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income rose 7.75% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 39.08% YoY), and the FY2025 full-year result was $5.5 million, up 179.12% from the prior year.
- Non Operating Income retreated to $1.2 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $2.1 million in Q2 2022 to a low of -$837000.0 in Q1 2024.
- A 5-year average of $1.0 million and a median of $1.3 million in 2024 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income jumped 1346.58% in 2022 and tumbled 156.94% in 2024, its largest moves.
- Tracing RZLT's Non Operating Income over 5 years: stood at $836000.0 in 2022, then jumped by 53.71% to $1.3 million in 2023, then rose by 5.06% to $1.3 million in 2024, then increased by 7.19% to $1.4 million in 2025, then fell by 17.42% to $1.2 million in 2026.
- Business Quant data shows RZLT's Non Operating Income at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | -837,000.00 |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 836,000.00 |
| Sep 30, 2022 | 387,000.00 |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | -454,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | -196,000.00 |
| Jun 30, 2021 | 146,000.00 |